A highly sensitive blood test detected disease-causing antibodies in a case of myasthenia gravis (MG) believed to be induced by COVID-19. The case underscores the importance of such diagnostic tools to detect disease markers that may be missed by the current approach in diagnosing MG, researchers said. It also shows the clinical benefits of immunosuppressants to treat the disorder. The case report, “Myasthenia gravis associated with anti‐MuSK antibodies developed after SARS‐CoV‐2 infection,” appeared in the…

You must be logged in to read/download the full post.